India’s burgeoning senior population is rapidly shifting the country’s demographic landscape, creating an undeniable imperative for comprehensive, empathetic eldercare solutions. In this critical and underserved segment, Age Care Labs has emerged as a frontrunner, strategically building a full-stack “continuum of care” that addresses the diverse needs of seniors. The Gurugram-based innovator has now secured ₹85 crore, marking a significant initial close towards its larger ₹250 crore Series B funding round. This capital infusion is not merely a financial transaction; it is a powerful validation of Age Care Labs’ vision and its meticulous approach to serving a demographic that deserves nothing less than dignity, specialized support, and vibrant independent living options. This investment underscores a growing investor confidence in India’s ‘silver economy’ and Age Care Labs’ unique position to lead its transformation.
About Age Care Labs: Pioneering a Holistic Approach to Eldercare
Founded in 2019, Age Care Labs embarked on a mission to redefine eldercare in India, moving beyond fragmented services to offer an integrated, evolving ecosystem of support. Co-founder and Chief Executive Saumyajit Roy envisioned a platform that could cater to seniors at every stage of their lives, from active independence to specialized medical and palliative care. This philosophy gave birth to a multi-brand strategy, meticulously crafted to provide tailored solutions.
At its core, Age Care Labs operates two well-established brands:
and
. Emoha serves as an app-based at-home care service, designed for seniors who predominantly live independently but require assistance with daily tasks, health monitoring, social engagement, and emergency support. It’s about empowering seniors to age in place, surrounded by the comfort of their own homes and communities, while having a reliable support system just a tap away.
Complementing Emoha is Epoch, a brand dedicated to providing advanced assisted living and specialized eldercare services. Epoch facilities offer a nurturing environment for seniors requiring more intensive support, including dementia care, palliative care, recovery and rehabilitation following medical procedures, and long-term care for chronic conditions. These centers are staffed by trained professionals, ensuring round-the-clock care, medical supervision, and an enriching living experience tailored to individual needs.
The synergy between Emoha and Epoch has allowed Age Care Labs to build a robust foundation, demonstrating its capacity to manage both technology-driven at-home services and high-touch, facility-based care. The company’s trajectory has been marked by a clear understanding of market gaps and a commitment to filling them with quality, compassion, and innovation. This comprehensive approach differentiates Age Care Labs in a landscape often characterized by single-service providers, enabling them to build a lasting relationship with seniors and their families as their needs evolve.
The Deal: Strategic Capital for Ambitious Expansion
The current funding round saw Age Care Labs secure ₹85 crore, serving as a pivotal initial close towards its larger Series B target of ₹250 crore. This tranche brings together a mix of strategic and financial investors, signaling a strong belief in the company’s business model and growth potential.
Leading the charge in this investment were
, the venture capital arm of brokerage giant Zerodha, and
. They were joined by other prominent family offices and the
, whose participation is particularly strategic, extending beyond mere capital to include a new joint venture.
Rainmatter Capital’s continued involvement is noteworthy. They had previously participated in Age Care Labs’ $11 million Pre-Series B round in 2023, alongside Gruhas, the venture capital fund co-founded by Nikhil Kamath and Abhijeet Pai, and Lumis Partners, who anchored Age Care Labs in 2019. This repeat investment from Rainmatter underscores a long-term conviction in Age Care Labs’ leadership, its operational capabilities, and the immense market opportunity it addresses. Rainmatter’s thesis often leans towards ventures that solve fundamental societal problems, and eldercare certainly fits that description, particularly with its potential for scalable, technology-enabled solutions.
The participation of Shrem Group marks a significant partnership. Beyond their financial commitment, Shrem Group is collaborating with Age Care Labs to launch
, a new venture focused on senior independent living. This collaboration highlights the strategic nature of the investment, bringing together Age Care Labs’ domain expertise with Shrem Group’s experience, likely in real estate or hospitality, to create a new offering that perfectly complements Age Care Labs’ existing continuum. Such partnerships are invaluable, providing not just capital but also synergistic capabilities that accelerate market entry and build competitive advantage.
While the specific valuation for this tranche was not publicly disclosed, the interest from such diverse and seasoned investors suggests a healthy outlook on Age Care Labs’ future earnings potential and its strategic positioning within the rapidly expanding eldercare market. The company is actively seeking investors who can contribute strategic value and demonstrate a long-term commitment to building the business, indicating a discerning approach to its cap table.
Use of Funds: Deepening Penetration and Expanding the Continuum
The freshly raised ₹85 crore is earmarked for a clear and strategic deployment, focused on deepening market penetration and expanding Age Care Labs’ service offerings across key urban markets. A significant portion of this capital will fuel the launch and scaling of Shremoha, the new senior independent living venture formed in partnership with Shrem Group.
Co-founder and CEO Saumyajit Roy articulated the deployment strategy, emphasizing a concentrated effort on existing tier-1 and tier-2 urban centers. This approach prioritizes enhancing penetration and value creation within these established markets rather than immediate, broad geographical diversification. The focus will be on strengthening the operational backbone for Emoha’s at-home services, ensuring seamless delivery and expanding its reach within these cities. For Epoch, the capital will likely support the expansion of specialized care capacities and potentially the establishment of new assisted living facilities where demand is highest.
The launch of Shremoha is a critical component of this expansion. It represents Age Care Labs’ strategic move into the independent living segment, completing its “continuum of care” model. Shremoha will offer facilities where active seniors can reside independently, benefiting from a community environment, amenities, and optional support services, bridging the gap between entirely independent living and assisted care. This ensures that Age Care Labs can serve seniors across the entire spectrum of their needs, from proactive wellness to comprehensive medical support, all within a trusted ecosystem. The investment will be crucial for infrastructure development, staffing, and marketing efforts associated with this new vertical.
Beyond new ventures, the funds will also be channeled into technology enhancements for Emoha’s platform, optimizing user experience, integrating advanced health monitoring features, and improving backend operational efficiencies. Investing in talent acquisition, particularly for specialized care professionals and community managers for the new independent living facilities, will also be a priority, ensuring that growth is supported by skilled and compassionate human capital.
Market Opportunity: The ‘Silver Economy’ Beckons
India is on the cusp of a profound demographic transformation, often referred to as the ‘silver tsunami.’ With over 140 million adults currently over the age of 60, and this figure projected to surge to 231 million by 2036, the eldercare market is not just growing; it’s exploding. This demographic shift is creating a massive ‘silver economy’ market, which encompasses everything from hospitals and diagnostics to home healthcare, assisted living, and senior housing. Experts project this market to be worth an astounding $35 billion by 2036.
Age Care Labs is strategically positioned to capture a significant share of this burgeoning market. While the senior population is vast, the company is acutely focused on the roughly 40 million seniors residing in urban pockets, a segment that typically possesses higher disposable incomes, greater awareness of specialized services, and a pronounced need for quality, organized care due to changing family structures and migration patterns.
The competitive landscape, while evolving, still remains largely fragmented. Many players offer niche services, such as only at-home care or only senior living. What sets Age Care Labs apart is its “continuum of care” model. By offering Emoha (at-home), Epoch (assisted living), and now Shremoha (independent living), the company provides a seamless, integrated solution that adapts as a senior’s needs change. This full-stack approach reduces the burden on families to find disparate services and ensures consistent quality of care under one trusted umbrella.
The partnership with Shrem Group for Shremoha further strengthens this unique positioning. It allows Age Care Labs to leverage external expertise and capital for asset-heavy ventures like independent living facilities, while maintaining its core focus on service delivery and technology. This hybrid model, combining direct services with strategic partnerships, enables faster scaling and diversified revenue streams, creating a significant moat in a market where trust and comprehensive offerings are paramount. The company’s neighborhood-based retirement community model, as described by Saumyajit Roy, positions it uniquely to foster community and convenience, differentiating it from more isolated or institution-like offerings.
What’s Next: Expanding Reach and Enhancing Value
With this initial close of its Series B round, Age Care Labs is poised for a period of accelerated growth and enhanced service delivery. The immediate focus remains squarely on deepening its presence and value creation within its chosen tier-1 and tier-2 urban markets. This isn’t about rapid, unchecked expansion, but rather a deliberate strategy to solidify its leadership in key demographic centers.
The launch of Shremoha will be a significant milestone, adding a crucial component to Age Care Labs’ holistic eldercare ecosystem. This venture will not only provide independent living options but also serve as a hub for community engagement and wellness programs for active seniors. Expect to see the initial Shremoha facilities come online and begin welcoming residents, setting a new standard for senior living in urban India.
Looking ahead, Age Care Labs will continue to invest in its technology platform, particularly for Emoha, to integrate more advanced predictive analytics, personalized care plans, and seamless digital engagement tools. This technological edge will be crucial in scaling its at-home services efficiently and maintaining high levels of satisfaction. The company will also continue to explore strategic partnerships that can further enhance its offerings, much like the collaboration with Shrem Group.
The remaining portion of the ₹250 crore Series B round is anticipated to close in the first quarter of 2027. This suggests Age Care Labs is engaged in ongoing discussions with potential investors, likely seeking those who bring not just capital but also strategic insights and a shared long-term vision for transforming eldercare in India. The company’s meticulous approach to building its cap table reflects a mature understanding of venture growth beyond mere fundraising. The ambition is clear: to become the undisputed leader in India’s eldercare continuum, providing comprehensive, compassionate, and technologically advanced solutions that empower seniors to live their best lives. The journey ahead for Age Care Labs promises to be impactful, not just for its stakeholders, but for millions of Indian families navigating the complexities of eldercare.